Cue Biopharma, Inc. (CUE)

0.418 -0.04 (-9.62%) USD  |  NASDAQ  |  Dec 16, 16:00
0.41 -0.01 (-1.91%) After-Hours: 20:00
More

Cue Biopharma Research and Development Expense (Annual): 35.93M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Insmed, Inc. 598.37M
Puma Biotechnology, Inc. 54.94M
Mersana Therapeutics, Inc. 73.02M
Adaptive Biotechnologies Corp. 94.33M
NovaBay Pharmaceuticals, Inc. 0.042M